Cargando…
RNA-seq analysis of blood of valproic acid-responsive and non-responsive pediatric patients with epilepsy
Epilepsy is the most common chronic neurological disorder, affecting ~70 million individuals worldwide. However, approximately one-third of the patients are refractory to epilepsy medication. Of note, 100% of patients with genetic epilepsy who are resistant to the traditional drug, valproic acid (VP...
Autores principales: | Wang, Yan, Li, Zhiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566089/ https://www.ncbi.nlm.nih.gov/pubmed/31258675 http://dx.doi.org/10.3892/etm.2019.7538 |
Ejemplares similares
-
Overexpression of Homer1b/c induces valproic acid resistance in epilepsy
por: Wang, Yan, et al.
Publicado: (2022) -
Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy
por: Tseng, Yu-Lung, et al.
Publicado: (2014) -
Clinical Validation and Implications of Dried Blood Spot Sampling of Carbamazepine, Valproic Acid and Phenytoin in Patients with Epilepsy
por: Kong, Sing Teang, et al.
Publicado: (2014) -
RNA-Seq data on prefrontal cortex in valproic acid model of autism and control rats
por: Qian, Zhaoqiang, et al.
Publicado: (2018) -
MicroRNA-134 plasma levels before and after treatment with valproic acid for epilepsy patients
por: Wang, Xiaofeng, et al.
Publicado: (2017)